Profil clinicobiologique, thérapeutique et évolutif des patients infectés par le VIH hospitalisés au service des maladies infectieuses et tropicales d’Abidjan (Côte d’Ivoire)

Abstract

The objective of this study is to describe the clinical, biological, therapeutic and evolving current profile of hospitalized patients with HIV infection in the cohort of the Infectious and Tropical Diseases Unit (ITDU) in the aim to improve their care management. This is a retrospective study, conducted on medical data of hospitalized cases of patients with HIV infection in the ITDU at the teaching hospital of Treichville (Abidjan) from 2006 to 2007. During the two years, 447 patients were included in the study. Their average age was 39 years [18 years-86 years] and sex ratio was 0.69. Of the 447 patients, 35% were unemployed and 67% were new patients who had never undergone antiretroviral therapy (ART). The duration of drug exposure was less than 6 months in 59% of treated patients. The average time to initiate ART was seven weeks. Among naive patients 41.9% were lost to follow up, 35.9% were waiting for treatment and 22.1% waiting for baseline biological test to initiate ART. At the initiation of ART, 79.6% of patients had a CD4 count less than 200/mm(3). The reasons of hospitalization defining AIDS were dominated by tuberculosis (34.2%), cerebral toxoplasmosis (17.9%) and neuromeningeal cryptococcosis (8%). The main reasons of hospitalization in classifying non-AIDS were pyelonephritis (6.5%), bacterial pneumonia (5.4%) and undetermined infectious encephalitis (4.9%). Hospital mortality was 24.4%. The leading causes of death were tuberculosis (22.9%), cerebral toxoplasmosis (20.2%), undetermined infectious encephalitis (18.3%) and cryptococcal meningitis (13.7%). The profile of PLHIV in hospital is characterized by profound immunosuppression due to late diagnosis and high mortality associated with severe opportunistic infections and late initiation of ART.

Profil clinique et immunologique des patients infectés par le VIH à l’initiation du traitement antirétroviral à Douala

“…Ceci est en conformité avec les résultats de Kouanfack et al qui avaient retrouvé au Cameroun un délai médian de 2,3 mois (18). Par contre, Kra et al avaient trouvé un délai de 5 mois (19). Ce délai dans cette étude est réduit, car les patients se trouvaient déjà à un stade avancé de la maladie au moment de l'initiation du TARV.…”

Disease patterns and causes of death of hospitalized HIV‐positive adults in West Africa: a multicountry survey in the antiretroviral treatment era

“…Available data come mainly from research protocols, clinical trials or specifically designed cohort studies, which may differ from routine programs by the selection of the population and by the means engaged to diagnose clinical events. Moreover, most available data concerning hospitalizations come from retrospective studies [18–22]. …”

Clinical and Immunological Characteristics in HIV-Infected Patients at the Treatment Initiation at the University Hospital of Parakou (Benin)

“…Zannou [6] and Kra [7] had also made the same remark. Whereas Shen et al [8] reported a male predominance.…”

“…According to Kra [7] the reasons of hospitalisation were dominated by tuberculosis (34.2%), cerebral toxoplasmosis (17.9%) and neuromeningeal cryptococcosis (8%).…”